Troglitazone Inhibits Growth of MCF-7 Breast Carcinoma Cells by Targeting G1 Cell Cycle Regulators
- 1 September 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 286 (5), 916-922
- https://doi.org/10.1006/bbrc.2001.5491
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Peroxisome Proliferator-activated Receptor γ Ligands Inhibit Retinoblastoma Phosphorylation and G1 → S Transition in Vascular Smooth Muscle CellsJournal of Biological Chemistry, 2000
- Roles of PPARs in health and diseaseNature, 2000
- An Essential Regulator of Adipogenesis and Modulator of Fat Cell Function: PPARγCell, 1999
- PPARγ-Ligands Inhibit Migration Mediated by Multiple Chemoattractants in Vascular Smooth Muscle CellsJournal of Cardiovascular Pharmacology, 1999
- Peroxisome Proliferator-activated Receptor γ Ligands Are Potent Inhibitors of Angiogenesis in Vitro and in VivoJournal of Biological Chemistry, 1999
- Differentiation and reversal of malignant changes in colon cancer through PPARγNature Medicine, 1998
- Ligands for peroxisome proliferator-activated receptorγ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX miceProceedings of the National Academy of Sciences, 1998
- Terminal Differentiation of Human Breast Cancer through PPARγMolecular Cell, 1998
- Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptorProceedings of the National Academy of Sciences, 1997
- Characterization of a candidate bcl-1 gene.Molecular and Cellular Biology, 1991